KOSDAQ · Healthcare · ₩38B
₩2,890-2.36%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 4.4% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“결핵백신의 글로벌 진전이 회사의 다음 성장을 여는 열쇠예요.”
In the company's words · 2026 2분기 filing